Mosunetuzumab Shows Promising Efficacy in Patients With Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience From a Phase 1 Dose-Escalation Trial

BLOOD(2021)

引用 42|浏览84
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要